Publications

The HAV™ is an investigational product and has not been approved for sale by the FDA or any other regulatory agency.

Publications

"Evaluation of tissue-engineered human acellular vessels as a Blalock–Taussig–Thomas shunt in a juvenile primate model"– 2023

"Evaluation of vascular repair by tissue-engineered human acellular vessels or expanded polytetrafluoroethylene grafts in a porcine model of limb ischemia and reperfusion"– 2023

"Biological mechanisms of infection resistance in tissue engineered blood vessels compared to synthetic expanded polytetrafluoroethylene grafts"– 2023

"Use of bioengineered human acellular vessels to treat traumatic injuries in the Ukraine–Russia conflict"– 2023

"Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass"– 2023

"Preliminary Experience With the Human Acellular Vessel: A Descriptive Case Series Detailing Early Use of a Bioengineered Blood Vessel for Arterial Repair"– 2022

"Bioengineering Human Tissues and the Future of Vascular Replacement"– 2022

"The Human Acellular Vessel for Vascular Reconstruction or Bypass A Novel Biologic Conduit for Vascular Bypass and Repair"– 2022

"Five Year Outcomes in Patients with End Stage Renal Disease Who Received a Bioengineered Human Acellular Vessel for Dialysis Access"– 2022

"Surgical Management of an Infected External Iliac Artery Interposition Graft with a Bioengineered Human Acellular Vessel" – 2021

"Development of a Bioartificial Vascular Pancreas" – 2021

"Patency of ePTFE Arteriovenous Graft Placements in Hemodialysis Patients: Systematic Literature Review and Meta-analysis" – 2020

"Arterial Reconstruction with Human Bioengineered Acellular Blood Vessels in Patients with Peripheral Arterial Disease"
– 2020

"Bioengineered Human Blood Vessels" – 2020

"Challenges and Novel Therapies for Vascular Access in Haemodialysis" – 2020

"Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage 2012-2014" – 2020

"Bioengineered Human Acellular Vessels Recellularize and Evolve into Living Blood Vessels after Human Implantation" – 2019

"Clinical Implementation of the Humacyte Human Acellular Vessel: Implications for Military and Civilian Trauma Care"– 2019

"Cost Attributable to Arteriovenous Fistulae And Arteriovenous Graft Placements in Hemodialysis Patients with Medicare Coverage"– 2019

"Susceptibility of EPTFE Vascular Grafts and Bioengineered Human Acellular Vessels to Infection"– 2018

Screen-Shot-2021-06-03-at-7.08.57-PM.png

"Arteriovenous Fistulae for Hemodialysis: A Systematic Review and Meta-Anaylsis of Efficacy and Safety Outcomes"– 2017

Screen-Shot-2021-06-03-at-7.10.38-PM.png

"Bioengineered Hemodialysis Access Graft"
– 2017

Screen-Shot-2021-06-03-at-7.13.12-PM.png

"Bioengineered Human Acellular Vessels for Dialysis Access in Patients with End-Stage Renal Disease: Two Phase 2 Single-Arm Trials"– 2016

Screen-Shot-2021-06-03-at-7.15.50-PM.png

"An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia"– 2011

Screen-Shot-2021-06-03-at-6.40.19-PM.png

"Readily Available Tissue-Engineered Vascular Grafts"– 2011

Screen-Shot-2021-06-03-at-6.40.19-PM.png

"Functional Arteries Grown in Vitro"– 1999

Scroll to Top